Dina Berdieva leads Project Management and Clinical Operations for the Bill & Melinda Gates Medical Research Institute. Dina has 18 years of industry experience which spans contract research organizations, small biotechnology and global pharmaceutical companies. Prior to joining Gates MRI she was the Executive Director of Clinical Operations for Boston Pharmaceuticals, an early phase translational medicine company. Dina also worked at Novartis Vaccines for almost nine years in various roles with increasing responsibility. During her time at Novartis, she oversaw global trials which led to regulatory approval for Flucelvax, Bexsero and an expanded indication for Menveo in children.
Dina grew up in Asia and Africa, earned her bachelor’s degree from Clark University and her Master’s in Public Health from Boston University.